Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01216241 · ClinicalTrials.gov registry record · Phase 3
Daptomycin Versus Placebo in Patients With Neutropenia and Fever
A Phase 3 study, sponsored by University of Rochester.
- Terminated
- Registry status
- Phase 3
- Development phase
- 36
- Enrollment target
NCT01216241 is a Phase 3 study that was terminated before completion, run by University of Rochester. The registered enrollment target is 36 participants.
The verdict
NCT01216241, a Phase 3 study, was terminated before completion, sponsored by University of Rochester.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 36 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the benefits and side effects of daptomycin compared to placebo for the treatment of neutropenic fever.
Interventions
- OTHER Saline Placebo
- DRUG Daptomycin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2011-04 |
| Est. Completion | 2013-04 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01216241
The ClinicalTrials.gov registry entry for NCT01216241 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Saline Placebo is the first listed.
NCT01216241 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01216241 about?
NCT01216241 is a clinical study titled "Daptomycin Versus Placebo in Patients With Neutropenia and Fever". The purpose of this study is to evaluate the benefits and side effects of daptomycin compared to placebo for the treatment of neutropenic fever.
What is the current status of trial NCT01216241?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 36 participants. The study started on 2011-04. Estimated completion is 2013-04.
What interventions are being tested in trial NCT01216241?
The interventions under investigation include: Saline Placebo (OTHER), Daptomycin (DRUG).
Who is sponsoring clinical trial NCT01216241?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.